600211 西藏药业
交易中 07-02 10:14:55
资讯
新帖
简况
西藏药业(600211)披露回购股份进展公告,7月1日股价上涨2.65%
证券之星 · 07-01 23:12
西藏药业(600211)披露回购股份进展公告,7月1日股价上涨2.65%
西藏药业涨6.74%,华鑫证券二个月前给出“买入”评级
证券之星 · 06-29 16:28
西藏药业涨6.74%,华鑫证券二个月前给出“买入”评级
西藏药业:生产端智能化升级已成为公司降本增效、强化产品质量的重要方向
证券之星 · 06-24
西藏药业:生产端智能化升级已成为公司降本增效、强化产品质量的重要方向
西藏药业:公司已围绕AI技术在生产、研发、供应链、营销预测、人员等多个环节开展了实质性探索
证券之星 · 06-24
西藏药业:公司已围绕AI技术在生产、研发、供应链、营销预测、人员等多个环节开展了实质性探索
西藏药业(600211)披露回购股份进展公告,6月1日股价下跌0.36%
证券之星 · 06-01
西藏药业(600211)披露回购股份进展公告,6月1日股价下跌0.36%
每周股票复盘:西藏药业(600211)每股派现0.876元
证券之星 · 05-17
每周股票复盘:西藏药业(600211)每股派现0.876元
西藏药业(600211)披露2025年年度权益分派实施公告,5月14日股价下跌1.49%
证券之星 · 05-14
西藏药业(600211)披露2025年年度权益分派实施公告,5月14日股价下跌1.49%
每周股票复盘:西藏药业(600211)回购耗资1.78亿用于股权激励
证券之星 · 05-10
每周股票复盘:西藏药业(600211)回购耗资1.78亿用于股权激励
西藏药业(600211)披露回购股份进展公告,5月8日股价上涨0.33%
证券之星 · 05-08
西藏药业(600211)披露回购股份进展公告,5月8日股价上涨0.33%
每周股票复盘:西藏药业(600211)Q1净利增10.93%
证券之星 · 05-02
每周股票复盘:西藏药业(600211)Q1净利增10.93%
西藏药业(600211)3月31日股东户数4.31万户,较上期增加0.7%
证券之星 · 04-28
西藏药业(600211)3月31日股东户数4.31万户,较上期增加0.7%
每周股票复盘:西藏药业(600211)华西药业质押展期1,876万股
证券之星 · 04-19
每周股票复盘:西藏药业(600211)华西药业质押展期1,876万股
中国经济网报道 | 扎根雪域守初心 锚定双径谋发展 西藏药业勇担“西藏的药业”时代使命
市场资讯 · 04-16
中国经济网报道 | 扎根雪域守初心 锚定双径谋发展 西藏药业勇担“西藏的药业”时代使命
每周股票复盘:西藏药业(600211)将召开2025年年度股东会
证券之星 · 04-12
每周股票复盘:西藏药业(600211)将召开2025年年度股东会
西藏药业(600211)披露2025年年度股东会召开提示性公告,4月7日股价下跌0.19%
证券之星 · 04-07
西藏药业(600211)披露2025年年度股东会召开提示性公告,4月7日股价下跌0.19%
每周股票复盘:西藏药业(600211)回购耗资1.78亿拟用于股权激励
证券之星 · 04-05
每周股票复盘:西藏药业(600211)回购耗资1.78亿拟用于股权激励
股市必读:西藏药业(600211)3月23日收盘跌7.02%,主力净流出1183.84万元
证券之星 · 03-24
股市必读:西藏药业(600211)3月23日收盘跌7.02%,主力净流出1183.84万元
花旗:维持康哲药业“买入”评级 目标价上调至17.5港元
智通财经 · 03-18
花旗:维持康哲药业“买入”评级 目标价上调至17.5港元
西藏药业(600211.SH)发布2025年度业绩,归母净利润9.38亿元,同比下降10.78%
智通财经 · 03-12
西藏药业(600211.SH)发布2025年度业绩,归母净利润9.38亿元,同比下降10.78%
每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%
证券之星 · 03-08
每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%
加载更多
公司概况
公司名称:
西藏诺迪康药业股份有限公司
所属行业:
医药制造业
上市日期:
1999-07-21
主营业务:
西藏诺迪康药业股份有限公司的主营业务是生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等。公司的主要产品是新活素、依姆多、诺迪康、十味蒂达胶囊、雪山金罗汉止痛涂膜剂、小儿双清颗粒。近年来,公司先后荣获“西藏自治区专精特新中小企业”“主板上市公司价值100强”“农业产业化国家重点龙头企业”、中国创新药价值排行榜双榜:“综合实力榜TOP50”与“生物药榜TOP20”“2025大健康卓越竞争力上市公司”,连续荣获“金牛最具投资价值奖”“上市公司董事会秘书履职评价4A评级”等多项荣誉。
发行价格:
6.00
{"stockData":{"symbol":"600211","market":"SH","secType":"STK","nameCN":"西藏药业","latestPrice":38.3,"timestamp":1782958495000,"preClose":38.38,"halted":0,"volume":2500237,"delay":0,"changeRate":-0.0021,"floatShares":322000000,"shares":322000000,"eps":3.0013,"marketStatus":"交易中","change":-0.08,"latestTime":"07-02 10:14:55","open":38.39,"high":39.43,"low":38.2,"amount":96693200,"amplitude":0.032,"askPrice":38.31,"askSize":1,"bidPrice":38.3,"bidSize":25,"shortable":0,"etf":0,"ttmEps":3.0013,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1782963000000},"marketStatusCode":2,"adr":0,"adjPreClose":38.38,"symbolType":"stock","openAndCloseTimeList":[[1782955800000,1782963000000],[1782968400000,1782975600000]],"highLimit":42.22,"lowLimit":34.54,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":322319196,"isCdr":false,"pbRate":3.17,"roa":"--","peRate":12.761137,"roe":"7.58%","epsLYR":2.91,"committee":0.881481,"marketValue":12345000000,"turnoverRate":0.0078,"status":1,"floatMarketCap":12345000000},"requestUrl":"/m/hq/s/600211","defaultTab":"news","newsList":[{"id":"2648159544","title":"西藏药业(600211)披露回购股份进展公告,7月1日股价上涨2.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648159544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648159544?lang=zh_cn&edition=full","pubTime":"2026-07-01 23:12","pubTimestamp":1782918738,"startTime":"0","endTime":"0","summary":"近日,西藏诺迪康药业股份有限公司发布《关于回购股份的进展公告》。公告显示,公司于2025年12月18日召开董事会,审议通过以集中竞价交易方式回购股份的议案,回购资金总额不低于17,000万元且不高于20,000万元,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。截至2026年6月底,公司累计回购股份4,000,058股,占总股本的1.24%,已支付金额177,595,651.46元,回购最高价为45.98元/股,最低价为42.66元/股。回购股份将用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600211","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647246123","title":"西藏药业涨6.74%,华鑫证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647246123","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647246123?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:28","pubTimestamp":1782721724,"startTime":"0","endTime":"0","summary":"今日西藏药业涨6.74%,收盘报38.0元。2026年4月12日,华鑫证券研究员胡博新,吴景欢发布了对西藏药业的研报《公司事件点评报告:存量业务稳健增长,布局创新药打造第二增长曲线》,该研报对西藏药业给出“买入”评级。维持“买入”投资评级。西藏药业个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645993458","title":"西藏药业:生产端智能化升级已成为公司降本增效、强化产品质量的重要方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2645993458","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645993458?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:30","pubTimestamp":1782293442,"startTime":"0","endTime":"0","summary":"请问两点:1. 公司是否已布局自动化生产设备与智能车间,结合AI实现生产全流程智能化管控?生产端智能化升级已成为公司降本增效、强化产品质量的重要方向。未来,公司将在现有基础上持续结合AI技术,对生产及质量管理体系进行优化升级,进一步提升运营效率与产品一致性,巩固质量竞争优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400031958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645899851","title":"西藏药业:公司已围绕AI技术在生产、研发、供应链、营销预测、人员等多个环节开展了实质性探索","url":"https://stock-news.laohu8.com/highlight/detail?id=2645899851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645899851?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:27","pubTimestamp":1782293245,"startTime":"0","endTime":"0","summary":"请问两点:1. 目前AI在营销、管理、质控等环节是否已实现降本提效?公司已围绕AI技术在生产、研发、供应链、营销预测、人员等多个环节开展了实质性探索,提升了运营效率和管理水平。后续公司将持续深化数字化建设、AI赋能公司精益化管理,为提质增效注入新动能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400031770.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","600211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640295055","title":"西藏药业(600211)披露回购股份进展公告,6月1日股价下跌0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640295055","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640295055?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:21","pubTimestamp":1780323678,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,西藏药业报收于38.4元,较前一交易日下跌0.36%,最新总市值为123.77亿元。近日,西藏药业发布《关于回购股份的进展公告》。公告显示,2025年12月18日,公司董事会审议通过回购股份方案,拟使用自有资金不低于17,000万元、不高于20,000万元,通过集中竞价交易方式回购股份,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。本次回购股份用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636906273","title":"每周股票复盘:西藏药业(600211)每股派现0.876元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636906273","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636906273?lang=zh_cn&edition=full","pubTime":"2026-05-17 05:01","pubTimestamp":1778965274,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,西藏药业报收于42.24元,较上周的41.94元上涨0.72%。本周,西藏药业5月12日盘中最高价报44.5元。本周关注点公司公告汇总:西藏药业每股派发现金红利0.876元(含税),股权登记日为2026年5月21日。公司公告汇总西藏诺迪康药业股份有限公司2025年年度权益分派实施公告:每股现金红利0.876元(含税),股权登记日为2026年5月21日,除权(息)日及现金红利发放日均为2026年5月22日。现金红利发放对象为股权登记日在册的全体A股股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635452887","title":"西藏药业(600211)披露2025年年度权益分派实施公告,5月14日股价下跌1.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635452887","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635452887?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:25","pubTimestamp":1778768716,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘,西藏药业报收于42.22元,较前一交易日下跌1.49%,最新总市值为136.08亿元。该股当日开盘42.72元,最高43.3元,最低42.16元,成交额达1.51亿元,换手率为1.1%。近日,西藏诺迪康药业股份有限公司发布《2025年年度权益分派实施公告》:每股现金红利0.876元(含税),股权登记日为2026年5月21日,除权(息)日及现金红利发放日均为2026年5月22日。现金红利发放对象为股权登记日在册的全体A股股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634414960","title":"每周股票复盘:西藏药业(600211)回购耗资1.78亿用于股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2634414960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634414960?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:32","pubTimestamp":1778351532,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,西藏药业报收于41.94元,较上周的40.46元上涨3.66%。本周,西藏药业5月8日盘中最高价报42.4元。本周关注点公司公告汇总:已累计回购4,0058股,支付金额177,595,651.46元,用于员工持股或股权激励。2026年4月未实施回购。本次回购股份将用于员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431329","title":"西藏药业(600211)披露回购股份进展公告,5月8日股价上涨0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633431329?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:37","pubTimestamp":1778233046,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,西藏药业报收于41.94元,较前一交易日上涨0.33%,最新总市值为135.18亿元。近日,西藏药业发布《关于回购股份的进展公告》。公告显示,2025年12月18日,公司召开董事会审议通过回购股份方案,拟使用自有资金不低于17,000万元、不高于20,000万元,通过集中竞价交易方式回购股份,回购价格不超过55元/股,回购期限为2025年12月18日至2026年12月17日。本次回购股份用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600211","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632476406","title":"每周股票复盘:西藏药业(600211)Q1净利增10.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632476406","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632476406?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:15","pubTimestamp":1777666512,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,西藏药业报收于40.46元,较上周的40.82元下跌0.88%。本周,西藏药业4月29日盘中最高价报41.6元。本周关注点来自业绩披露要点:西藏药业2026年一季报显示归母净利润2.99亿元,同比上升10.93%。股本股东变化股东户数变动截至2026年3月31日,西藏药业股东户数为4.31万户,较2月28日增加301.0户,增幅0.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630374838","title":"西藏药业(600211)3月31日股东户数4.31万户,较上期增加0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630374838","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630374838?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:31","pubTimestamp":1777368705,"startTime":"0","endTime":"0","summary":"证券之星消息,近日西藏药业披露,截至2026年3月31日公司股东户数为4.31万户,较2月28日增加301.0户,增幅为0.7%。在生物制品行业个股中,西藏药业股东户数高于行业平均水平,截至3月31日,生物制品行业平均股东户数为3.56万户。从股价来看,2026年2月28日至2026年3月31日,西藏药业区间跌幅为4.7%,在此期间股东户数增加301.0户,增幅为0.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800051260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628725759","title":"每周股票复盘:西藏药业(600211)华西药业质押展期1,876万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2628725759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628725759?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:12","pubTimestamp":1776539529,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,西藏药业报收于41.89元,较上周的42.26元下跌0.88%。本周,西藏药业4月15日盘中最高价报42.63元。4月14日盘中最低价报40.89元。西藏药业当前最新总市值135.02亿元,在生物制品板块市值排名23/51,在两市A股市值排名1554/5198。本次股份质押展期1,876万股,占其所持股份的33.41%,占公司总股本的5.82%。截至公告日,华西药业累计质押股份1,876万股,无限售和冻结情况。华西药业生产经营正常,具备履约能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627429322","title":"中国经济网报道 | 扎根雪域守初心 锚定双径谋发展 西藏药业勇担“西藏的药业”时代使命","url":"https://stock-news.laohu8.com/highlight/detail?id=2627429322","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627429322?lang=zh_cn&edition=full","pubTime":"2026-04-16 16:52","pubTimestamp":1776329520,"startTime":"0","endTime":"0","summary":"(来源:西藏药业)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-04-16/doc-inhusvkh1594771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ASHS","HXC","BK4585","ASHR","BK4588","KWEB","BK0239","BK4504","BK4614","DRAG","LU0963586101.USD","600211","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626812217","title":"每周股票复盘:西藏药业(600211)将召开2025年年度股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2626812217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626812217?lang=zh_cn&edition=full","pubTime":"2026-04-12 02:04","pubTimestamp":1775930653,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘,西藏药业报收于42.26元,较上周的42.0元上涨0.62%。本周,西藏药业4月10日盘中最高价报42.77元。西藏药业当前最新总市值136.21亿元,在生物制品板块市值排名23/51,在两市A股市值排名1502/5196。公司公告汇总西藏诺迪康药业股份有限公司将于2026年4月13日召开2025年年度股东会,会议采取现场投票与网络投票相结合方式,股权登记日为2026年4月2日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625995939","title":"西藏药业(600211)披露2025年年度股东会召开提示性公告,4月7日股价下跌0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625995939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625995939?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:40","pubTimestamp":1775554833,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,西藏药业报收于41.92元,较前一交易日下跌0.19%,最新总市值为135.12亿元。该股当日开盘42.04元,最高42.62元,最低41.3元,成交额达1.02亿元,换手率为0.75%。西藏诺迪康药业股份有限公司于近日发布《关于召开2025年年度股东会的提示性公告》。公告显示,公司定于2026年4月13日召开2025年年度股东会,会议采取现场投票与网络投票相结合方式,股权登记日为2026年4月2日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","600211","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625619806","title":"每周股票复盘:西藏药业(600211)回购耗资1.78亿拟用于股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2625619806","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625619806?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:47","pubTimestamp":1775328427,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,西藏药业报收于42.0元,较上周的40.82元上涨2.89%。本周,西藏药业4月2日盘中最高价报43.43元。回购股份拟用于员工持股计划或股权激励。业绩披露要点西藏诺迪康药业股份有限公司2025年年度报告及董事会工作报告显示,公司2025年实现营业收入29.82亿元,同比增长6.23%;归属于上市公司股东的净利润9.38亿元,同比下降10.78%,主要因其他收益减少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621085211","title":"股市必读:西藏药业(600211)3月23日收盘跌7.02%,主力净流出1183.84万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621085211","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621085211?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:18","pubTimestamp":1774289895,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,西藏药业报收于39.44元,下跌7.02%,换手率2.15%,成交量6.93万手,成交额2.79亿元。来自资金流向:3月23日主力资金净流出1183.84万元,占总成交额4.25%。交易信息汇总股价提醒3月23日西藏药业收盘报39.44元,跌7.02%,当日成交692.88万元。该股已连续3日下跌。前10个交易日主力资金累计净流出5729.22万元,股价累计下跌5.5%;融资余额累计减少176.42万元,融券余量累计增加2.29万股。最近90天内共有1家机构给出评级,均为买入评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620528572","title":"花旗:维持康哲药业“买入”评级 目标价上调至17.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620528572","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620528572?lang=zh_cn&edition=full","pubTime":"2026-03-18 11:29","pubTimestamp":1773804540,"startTime":"0","endTime":"0","summary":"花旗发布研报称,维持康哲药业(00867)“买入”评级,根据管理层最新对创新药快速增长的指引,该行上调2026及2027年收入预测1%及4%,每股盈利预测上调1%及13%;将目标价由16.6港元上调至17.5 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260318/c675372644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["600211","BK0033","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618138455","title":"西藏药业(600211.SH)发布2025年度业绩,归母净利润9.38亿元,同比下降10.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138455","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618138455?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:05","pubTimestamp":1773309928,"startTime":"0","endTime":"0","summary":"智通财经APP讯,西藏药业(600211.SH)披露2025年年度报告,报告期公司实现营收29.82亿元,同比增长6.23%;归属于上市公司股东的净利润9.38亿元,同比下降10.78%;扣非净利润8.71亿元,同比增长1.48%;基本每股收益2.91元。公司拟向全体股东按每10股派发现金8.76元(含税)。报告期内,在宏观环境复杂多变、产业政策动态演进的背景下,深入贯彻董事会战略部署,积极适应新时期的新要求,提升内部管理水平、拓展销售渠道、挖掘市场潜力、注重人才培养和团队建设,坚持以公司战略目标和年度经营目标为指引,按计划有序开展各项经营工作,公司经营情况总体保持平稳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413163.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"西藏药业(600211.SH)发布2025年度业绩,归母净利润9.38亿元,同比下降10.78%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617266359","title":"每周股票复盘:西藏药业(600211)回购金额达1.78亿元,占总股本1.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617266359","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617266359?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:09","pubTimestamp":1772910551,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘,西藏药业报收于42.43元,较上周的42.58元下跌0.35%。本周,西藏药业3月3日盘中最高价报42.78元。西藏药业当前最新总市值136.76亿元,在生物制品板块市值排名22/51,在两市A股市值排名1553/5190。本周关注点公司公告汇总:截至2026年2月底,公司累计回购股份4,000,058股,占总股本的1.24%,已支付总金额177,595,651.46元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600211","BK0239","BK0033"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782958500937,"stockEarnings":[{"period":"1week","weight":0.0226},{"period":"1month","weight":-0.0005},{"period":"3month","weight":-0.0876},{"period":"6month","weight":-0.0786},{"period":"1year","weight":0.0844},{"period":"ytd","weight":-0.0786}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0135},{"period":"3month","weight":0.0493},{"period":"6month","weight":0.0362},{"period":"1year","weight":0.1893},{"period":"ytd","weight":0.0362}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏诺迪康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"43143人(较上一季度增加0.70%)","perCapita":"7470股","listingDate":"1999-07-21","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区A区广州路3号","registeredCapital":"32231万元","survey":" 西藏诺迪康药业股份有限公司的主营业务是生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等。公司的主要产品是新活素、依姆多、诺迪康、十味蒂达胶囊、雪山金罗汉止痛涂膜剂、小儿双清颗粒。近年来,公司先后荣获“西藏自治区专精特新中小企业”“主板上市公司价值100强”“农业产业化国家重点龙头企业”、中国创新药价值排行榜双榜:“综合实力榜TOP50”与“生物药榜TOP20”“2025大健康卓越竞争力上市公司”,连续荣获“金牛最具投资价值奖”“上市公司董事会秘书履职评价4A评级”等多项荣誉。","listedPrice":6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西藏药业(600211)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西藏药业(600211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西藏药业,600211,西藏药业股票,西藏药业股票老虎,西藏药业股票老虎国际,西藏药业行情,西藏药业股票行情,西藏药业股价,西藏药业股市,西藏药业股票价格,西藏药业股票交易,西藏药业股票购买,西藏药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西藏药业(600211)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西藏药业(600211)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}